Ecuador Medical Device Registration 2026: Registration Holder (Titular) Structure and Responsibilities

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Ecuador applies a registration holder (Titular del Registro Sanitario) system for medical devices: under Article 5, the sanitary registration certificate is issued in the name of the registration holder, who is responsible for its use; Article 3 defines the holder as the natural or legal person to whom ARCSA grants the registration certificate; and Article 19 makes the holder answerable both for the truthfulness of the information it provides and for compliance with technical and sanitary requirements across manufacturing, storage, distribution, transport and sale of the devices registered under its name. Foreign manufacturers must hold their registrations through a local registration holder.

2. Legal basis

RegulationReference numberPublication dateArticle provisions
Substitute Technical Sanitary Regulation for the Registration, Control and Surveillance of Medical Devices for Human UseResolución ARCSA-DE-2026-003-DASPSigned 2026-04-28Article 5 (mandatory registration and registration holder), Article 19 (holder responsibilities)
Same regulationSameSameArticle 3 (definitions of registration holder, product owner, authorized representative, manufacturer)
Same regulationSameSameArticle 23(a) (operating permit number), Article 60 (establishment operating permit)

Core definitions under Article 3:

  • Registration holder (Titular del Registro Sanitario): the natural or legal person to whom ARCSA grants the sanitary registration certificate;
  • Product owner (Titular del producto): the natural or legal person that owns the product and places it on the market, which may be the manufacturer itself or a third party duly authorized by the manufacturer;
  • Authorized representative (Representante autorizado): the natural or legal person duly authorized by the product owner to act on its behalf in Ecuador;
  • Manufacturer (Fabricante): the natural or legal person that designs, produces, manufactures, assembles and finishes finished devices and commercializes them under its own name, and that is responsible for the design, manufacture, packaging and labeling of the devices, whether these operations are carried out by that person or by a third party.

3. Expert insights

Insight 1: Article 3 defines the product owner and the registration holder separately, and the two roles may be held by different entities. The product owner is the rights holder in the commercial sense, which may be the manufacturer or a third party authorized by it, while the registration holder is the responsible party in the regulatory sense. The new regulation does not require the two roles to be held by the same person, which preserves structural space for manufacturers from the Chinese mainland to remain the product owner themselves while a local entity serves as the registration holder.

Insight 2: Article 5 binds the name on the certificate to the responsibility for its use. The text provides that the sanitary registration will be issued in the name of the registration holder, that the holder will be responsible for its use, and that the uniform format approved by ARCSA will be adopted. This means the name printed on the certificate is the party that bears regulatory liability, and a foreign manufacturer cannot defend itself against the regulator by pointing to contractual indemnity clauses agreed with the holder.

Insight 3: The scope of responsibility under Article 19 covers five stages of the product life cycle. Manufacturing, storage, distribution, transport and sale: the registration holder is responsible for compliance with technical and sanitary requirements in all five stages, and not merely for the truthfulness of the submitted dossier. In practice this makes the holder an active compliance operator with duties that continue for as long as the devices remain on the market.

Insight 4: The operating permit constitutes a substantive threshold for any would-be registration holder. Article 23(a) requires the applicant to declare a valid operating permit number at the time of filing, and Article 60 requires any establishment engaged in manufacturing, import, distribution, storage or commercialization to hold a valid operating permit and to confine itself to the activities expressly listed in the permit document. An entity without a valid operating permit cannot act as a qualified registration holder.

Insight 5: Article 71 extends the holder’s responsibility into the distribution channel. The legal representative or technical director of device representative offices and distributors must keep, at their premises, the authorization issued by the registration holder for that distributor or office to distribute and commercialize the devices, so that ARCSA can verify it during surveillance and inspection activities. This creates a documented management obligation that runs from the registration holder down through every downstream channel partner.

4. Practical recommendations

  1. Clearly separate the product owner and the registration holder in the authorization structure, keeping the product owner as the entity on the side of the Chinese mainland.
  2. Verify the holder’s operating permit before signing: confirm that the permit is valid and that its listed scope of activities covers import and distribution.
  3. Define the holder’s specific compliance obligations for each of the five stages in the agreement, rather than relying on a general liability clause.
  4. Require the holder to establish an authorization management mechanism for downstream distributors, so that the on-site verification requirements of Article 71 can be met at any time.
  5. Evaluate a neutral registration holder structure: the certificate does not move when the distribution channel changes, which materially reduces channel risk.

5. Verification checklist

  • □ The roles of product owner and registration holder have been defined
  • □ The validity and activity scope of the holder’s operating permit have been verified
  • □ The agreement sets out the holder’s compliance obligations across the five stages
  • □ A mechanism to retain and verify downstream distributor authorizations is in place
  • □ The suitability of a neutral registration holder structure has been assessed
  • □ The certificate format has been confirmed against the uniform format required by ARCSA

Regulatory information verified as of October 29, 2026

GRZAN service note

GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, registration holder and licensing structure design, operating permit and BPADT verification, official fee and timeline estimation, technical dossier preparation, and post-market compliance management. Manufacturers and importers planning an Ecuador registration or restructuring an existing licensing arrangement may contact GRZAN at info@grzanglobal.com for a tailored solution.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail